4.7 Review

Application of Amorphous Calcium Phosphate Agents in the Prevention and Treatment of Enamel Demineralization

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fbioe.2022.853436

关键词

enamel; demineralization; remineralization; amorphous calcium phosphate; hydroxyapatite

资金

  1. National Natural Science Foundation of China [81901044]
  2. Chinese Stomatological Association COS Basic Research Fund [COS-B2021-08]
  3. Wuhan Young and Middle-aged Medical Talents Training Program [(2019)87]

向作者/读者索取更多资源

Enamel demineralization, a common dental problem, is a concern for dental professionals and patients due to its impact on both health and aesthetics. Amorphous calcium phosphate (ACP) has gained attention as a potential agent for preventing or treating enamel demineralization. This article briefly reviews ACP stabilizers and their mechanisms, as well as the scientific evidence supporting the remineralization ability of these agents. The limitations of current research and future prospects for clinical translation of ACP agents are also discussed.
Enamel demineralization, as a type of frequently-occurring dental problem that affects both the health and aesthetics of patients, is a concern for both dental professionals and patients. The main chemical composition of the enamel, hydroxyapatite, is easy to be dissolved under acid attack, resulting in the occurrence of enamel demineralization. Among agents for the preventing or treatment of enamel demineralization, amorphous calcium phosphate (ACP) has gradually become a focus of research. Based on the nonclassical crystallization theory, ACP can induce the formation of enamel-like hydroxyapatite and thereby achieve enamel remineralization. However, ACP has poor stability and tends to turn into hydroxyapatite in an aqueous solution resulting in the loss of remineralization ability. Therefore, ACP needs to be stabilized in an amorphous state before application. Herein, ACP stabilizers, including amelogenin and its analogs, casein phosphopeptides, polymers like chitosan derivatives, carboxymethylated PAMAM and polyelectrolytes, together with their mechanisms for stabilizing ACP are briefly reviewed. Scientific evidence supporting the remineralization ability of these ACP agents are introduced. Limitations of existing research and further prospects of ACP agents for clinical translation are also discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据